Gravitate Health FHIR Implementation Guide, published by Gravitate Health Project. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/gravitate-health/ and changes regularly. See the Directory of published versions
Read all of this leaflet carefully before the vaccine is given because it contains important information for you or your child.
What is in this leaflet:
Fluenz Tetra is a vaccine to prevent influenza (flu). It is used in children and adolescents 24 months to less than 18 years of age. Fluenz Tetra will help to protect against the four virus strains contained in the vaccine, and other strains closely related to them.
How Fluenz Tetra works
When a person is given the vaccine, the immune system (the body’s natural defence system) will produce its own protection against the influenza virus. None of the ingredients in the vaccine can cause the flu. Fluenz Tetra vaccine viruses are grown in chicken eggs. Each year the vaccine targets four strains of influenza, following the annual recommendations by the World Health Organisation.
You will not be given Fluenz Tetra:
Warnings and precautions
Talk to your doctor, nurse or pharmacist before vaccination:
If any of these apply, tell your doctor, nurse or pharmacist before vaccination. He or she will decide if Fluenz Tetra is suitable for you.
Other medicines, other vaccines and Fluenz Tetra
Tell your doctor, nurse or pharmacist if the person being vaccinated is taking, has recently taken or might take any other medicines, including medicines that do not require a prescription.
Your doctor, nurse or pharmacist will decide if Fluenz Tetra can be given at the same time as other vaccines.
Pregnancy and breast-feeding
Driving and using machines
Fluenz Tetra will be administered under the supervision of a doctor, nurse or pharmacist.
Fluenz Tetra must only be used as a nasal spray.
Fluenz Tetra must not be injected.
Fluenz Tetra will be given as a spray in each nostril. You can breathe normally while you are given Fluenz Tetra. You do not need to actively inhale or sniff.
Dosage
The recommended dose for children and adolescents is 0.2 ml Fluenz Tetra, administered as 0.1 ml in each nostril. Children who have not previously had an influenza vaccine will receive a second, follow-up dose after an interval of at least 4 weeks. Follow your doctor, nurse or pharmacist’s instructions about if and when your child should return for the second dose.
If you have any further questions on this vaccine, ask your doctor, nurse or pharmacist.
Like all medicines, this vaccine can cause side effects, although not everybody gets them. In clinical studies with the vaccine, most side effects were mild in nature and short term.
Ask your doctor, nurse or pharmacist if you want more information about possible side effects from Fluenz Tetra.
Some side effects may be serious
Very rare(may affect up to 1 in 10,000 people):
Tell your doctor straight away or seek urgent medical care if you experience any of the effects above.
Other possible side effects of Fluenz TetraVery common(may affect more than 1 in 10 people):
Common(may affect up to 1 in 10 people):
Uncommon(may affect up to 1 in 100 people):
Reporting of side effects
If you get any side effects, talk to your doctor, nurse or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects you can help provide more information on the safety of this medicine.
Keep this vaccine out of the sight and reach of children.
Do not use this vaccine after the expiry date which is stated on the applicator label after the letters EXP.
Store in a refrigerator (2°C to 8°C). Do not freeze.
Keep the nasal applicator in the outer carton in order to protect from light.
Before use, the vaccine may be taken out of the refrigerator once for a maximum period of 12 hours at a temperature not above 25°C. If the vaccine has not been used after this 12 hour period, it should be discarded.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
What Fluenz Tetra contains
The active substances are:
Reassortant influenza virus (live attenuated) of the following four strains*:
A/Victoria/4897/2022 (H1N1)pdm09 - like strain | E107.0±0.5 FFU* |
(A/Norway/31694/2022, MEDI 369815) | |
A/Darwin/9/2021 (H3N2) - like strain | E107.0±0.5 FFU* |
(A/Norway/16606/2021, MEDI 355293) | |
B/Austria/1359417/2021 - like strain | E107.0±0.5 FFU* |
(B/Austria/1359417/2021, MEDI 355292) | |
B/Phuket/3073/2013 - like strain | E107.0±0.5 FFU* |
(B/Phuket/3073/2013, MEDI 306444) | |
.................................................................................................................. | per 0.2 ml dose |
* propagated in fertilised hens' eggs from healthy chicken flocks. produced in VERO cells by reverse genetic technology. This product contains genetically modified organisms (GMOs).* fluorescent focus units.
This vaccine complies with the WHO (World Health Organisation) recommendations (Northern Hemisphere) and EU decision for the 2023/2024 season.
The other ingredients are sucrose, dipotassium phosphate, potassium dihydrogen phosphate, gelatin (porcine, Type A), arginine hydrochloride, monosodium glutamate monohydrate and water for injections.
What Fluenz Tetra looks like and contents of the pack
This vaccine is presented as a nasal spray suspension in a single-use nasal applicator (0.2 ml) in a pack size of 1 and 10. Not all pack sizes may be available in your country.
The suspension is colourless to pale yellow, clear to slightly cloudy. Small white particles may be present.
Full name: Fluenz Tetra nasal spray suspension
- Invented name part: Fluenz Tetra
- Scientific name part: Reassortant influenza virus* (live attenuated) of four strains
- Strength part:
- Pharmaceutical dose form part: Nasal Spray
Name usage: English (Denmark)
Authorised dose form:
Legal status of supply: Medicinal product subject to medical prescription
Domain: Human use
Resource status: active
Product classification:
Package 1 of 2
PMSWI: EU/1/13/887/003
Description:
Marketing status:
Pack size:
Package: 1 Box (Cardboard)
Containing:
Package: 1 Nasal applicator
Containing:
Manufactured Item
Dose form: Nasal spray
Unit of presentation: Spray
Ingredient
Role: Active
Substance: A/Victoria/4897/2022
Ingredient
Role: Active
Substance: A/Darwin/9/2021 (H3N2)
Ingredient
Role: Active
Substance: B/Austria/1359417/2021
Ingredient
Role: Active
Substance: B/Phuket/3073/2013 -
Ingredient
Role: Excipient
Substance: Sucrose
Ingredient
Role: Excipient
Substance: Dipotassium phosphate
Ingredient
Role: Excipient
Substance: Potassium dihydrogen phosphate
Ingredient
Role: Excipient
Substance: Gelatin (porcine, Type A)
Ingredient
Role: Excipient
Substance: Arginine hydrochloride
Ingredient
Role: Excipient
Substance: Monosodium glutamate monohydrate
Ingredient
Role: Excipient
Substance: Water for injections
Package 2 of 2
PMSWI: EU/1/13/887/004
Description:
Marketing status:
Pack size:
Package: 1 Box (Cardboard)
Containing:
Package: 10 Nasal applicator
Containing:
Manufactured Item
Dose form: Nasal spray
Unit of presentation: Spray
Ingredient
Role: Active
Substance: A/Victoria/4897/2022
Ingredient
Role: Active
Substance: A/Darwin/9/2021 (H3N2)
Ingredient
Role: Active
Substance: B/Austria/1359417/2021
Ingredient
Role: Active
Substance: B/Phuket/3073/2013 -
Ingredient
Role: Excipient
Substance: Sucrose
Ingredient
Role: Excipient
Substance: Dipotassium phosphate
Ingredient
Role: Excipient
Substance: Potassium dihydrogen phosphate
Ingredient
Role: Excipient
Substance: Gelatin (porcine, Type A)
Ingredient
Role: Excipient
Substance: Arginine hydrochloride
Ingredient
Role: Excipient
Substance: Monosodium glutamate monohydrate
Ingredient
Role: Excipient
Substance: Water for injections
Administrable Product (1 of 1)
Dose form: Nasal spray
Unit of presentation: Spray
Route of administration:
Ingredient
Role: Active
Substance: A/Victoria/4897/2022
Ingredient
Role: Active
Substance: A/Darwin/9/2021 (H3N2)
Ingredient
Role: Active
Substance: B/Austria/1359417/2021
Ingredient
Role: Active
Substance: B/Phuket/3073/2013 -
Ingredient
Role: Excipient
Substance: Sucrose
Ingredient
Role: Excipient
Substance: Dipotassium phosphate
Ingredient
Role: Excipient
Substance: Potassium dihydrogen phosphate
Ingredient
Role: Excipient
Substance: Gelatin (porcine, Type A)
Ingredient
Role: Excipient
Substance: Arginine hydrochloride
Ingredient
Role: Excipient
Substance: Monosodium glutamate monohydrate
Ingredient
Role: Excipient
Substance: Water for injections